Investors / Avoro Capital Advisors / Compare with Frazier Life Sciences

Avoro Capital Advisors vs Frazier Life Sciences

Avoro Capital Advisors lists 55 portfolio companies and has joined 2 funding rounds; Frazier Life Sciences lists 78 companies and has joined 17 rounds. Avoro Capital Advisors comes in most often at Series B (50% of its entries), Frazier Life Sciences comes in most often at Growth (44% of its entries). 5 companies are on both portfolios, among them Acerta Pharma, Adverum Biotechnologies and Amicus Therapeutics.

Avoro Capital AdvisorsView profilevsFrazier Life SciencesView profile

55Portfolio companies78

2Funding rounds joined17

1Rounds led6

1Rounds, last 12 months11

$100M or moreTypical round it comes in at$100M or more

0%Sites no longer answering0%

Show as a table

Avoro Capital Advisors and Frazier Life Sciences, head to head

	Avoro Capital Advisors	Frazier Life Sciences
Portfolio companies	55	78
Funding rounds joined	2	17
Rounds led	1	6
Rounds, last 12 months	1	11
Typical round it comes in at	$100M or more	$100M or more
Sites no longer answering	0%	0%

Companies both back

5

Acerta Pharmaacerta-pharma.comAdverum Biotechnologiesadverum.comAmicus Therapeuticsamicusrx.comAvidity Biosciencesaviditybiosciences.comKrystal Biotechkrystalbio.com

Shared companies are those both firms' own portfolio pages list, each checked against the company's site. The same comparison through the API is POST /v1/overlap, for up to 20 firms. How the data is graded

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/avorocapital.com/portfolio

# also
GET /v1/firms/frazierls.com/portfolio
GET /v1/firms/avorocapital.com/coinvestors